137 related articles for article (PubMed ID: 12867641)
21. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
[TBL] [Abstract][Full Text] [Related]
22. Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men.
Hagensee ME; Kiviat N; Critchlow CW; Hawes SE; Kuypers J; Holte S; Galloway DA
J Infect Dis; 1997 Sep; 176(3):625-31. PubMed ID: 9291307
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of human papillomavirus antibodies in young female subjects in England.
Jit M; Vyse A; Borrow R; Pebody R; Soldan K; Miller E
Br J Cancer; 2007 Oct; 97(7):989-91. PubMed ID: 17726462
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
[TBL] [Abstract][Full Text] [Related]
25. Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer.
Combita AL; Bravo MM; Touzé A; Orozco O; Coursaget P
Int J Cancer; 2002 Feb; 97(6):796-803. PubMed ID: 11857357
[TBL] [Abstract][Full Text] [Related]
26. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study.
Molano M; Van den Brule A; Plummer M; Weiderpass E; Posso H; Arslan A; Meijer CJ; Muñoz N; Franceschi S;
Am J Epidemiol; 2003 Sep; 158(5):486-94. PubMed ID: 12936904
[TBL] [Abstract][Full Text] [Related]
27. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil.
Nicol AF; Grinsztejn B; Friedman RK; Veloso VG; Cunha CB; Georg I; Pilotto JH; Moreira RI; Castro CA; Silver B; Viscidi RP
J Clin Virol; 2013 Jun; 57(2):147-51. PubMed ID: 23490398
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and stability of antibodies to 37 human papillomavirus types--a population-based longitudinal study.
Antonsson A; Green AC; Mallitt KA; O'Rourke PK; Pandeya N; Pawlita M; Waterboer T; Neale RE
Virology; 2010 Nov; 407(1):26-32. PubMed ID: 20723959
[TBL] [Abstract][Full Text] [Related]
29. Spectrum of genital human papillomavirus infection in a female adolescent population.
Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus infection is transient in young women: a population-based cohort study.
Evander M; Edlund K; Gustafsson A; Jonsson M; Karlsson R; Rylander E; Wadell G
J Infect Dis; 1995 Apr; 171(4):1026-30. PubMed ID: 7706782
[TBL] [Abstract][Full Text] [Related]
31. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
Rosales R; López-Contreras M; Cortes RR
J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus infection in women infected with the human immunodeficiency virus.
Sun XW; Kuhn L; Ellerbrock TV; Chiasson MA; Bush TJ; Wright TC
N Engl J Med; 1997 Nov; 337(19):1343-9. PubMed ID: 9358128
[TBL] [Abstract][Full Text] [Related]
33. [HPV infection in pregnant women].
Biernat I; Szczudrawa A; Tomaszczyk J; Ludwin A
Ginekol Pol; 2003 Oct; 74(10):1066-9. PubMed ID: 14669396
[TBL] [Abstract][Full Text] [Related]
34. The occurrence of genital types of human papillomavirus in normal pregnancy and in pregnant women with pregestational insulin dependent diabetes mellitus.
Gajewska M; Marianowski L; Wielgos M; Malejczyk M; Majewski S
Neuro Endocrinol Lett; 2005 Dec; 26(6):766-70. PubMed ID: 16380676
[TBL] [Abstract][Full Text] [Related]
35. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.
Rousseau MC; Pereira JS; Prado JC; Villa LL; Rohan TE; Franco EL
J Infect Dis; 2001 Dec; 184(12):1508-17. PubMed ID: 11740725
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.
Franco EL; Villa LL; Sobrinho JP; Prado JM; Rousseau MC; Désy M; Rohan TE
J Infect Dis; 1999 Nov; 180(5):1415-23. PubMed ID: 10515798
[TBL] [Abstract][Full Text] [Related]
37. Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States).
Hisada M; van den Berg BJ; Strickler HD; Christianson RE; Wright WE; Waters DJ; Rabkin CS
Cancer Causes Control; 2001 May; 12(4):335-41. PubMed ID: 11456229
[TBL] [Abstract][Full Text] [Related]
38. The epidemiology of human papillomavirus infections.
Baseman JG; Koutsky LA
J Clin Virol; 2005 Mar; 32 Suppl 1():S16-24. PubMed ID: 15753008
[TBL] [Abstract][Full Text] [Related]
39. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.
Fukuchi E; Sawaya GF; Chirenje M; Magure T; Tuveson J; Ma Y; Shiboski S; Da Costa M; Palefsky J; Moscicki AB; Makunike-Mutasa R; Chipato T; Smith-McCune KK
Sex Transm Dis; 2009 May; 36(5):305-11. PubMed ID: 19295468
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization.
Bollen LJ; Chuachoowong R; Kilmarx PH; Mock PA; Culnane M; Skunodom N; Chaowanachan T; Jetswang B; Neeyapun K; Asavapiriyanont S; Roongpisuthipong A; Wright TC; Tappero JW
Sex Transm Dis; 2006 Apr; 33(4):259-64. PubMed ID: 16452834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
